美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

NexGel Equity Warrant Exp 17th Dec 2026 Warrant

0.0592

+0.009218.40%

成交量：4,762.00

成交额：203.60

市值：47.76万

市盈率：-0.16

高：0.0592

开：0.0456

低：0.0401

收：0.0500

52周最高：0.4958

52周最低：0.0377

股本：806.76万

流通股本：806.76万

量比：0.08

换手率：0.06%

股息：- -

股息率：- -

每股收益(TTM):-0.3796

净资产收益率：-60.47%

总资产收益率：-19.51%

市净率：0.10

市盈率(LYR):- -

数据加载中...

总览公司新闻资讯公告

Nexgel披露授权与收购商业化阶段再生生物材料产品组合协议的具体条款

Nexgel达成协议预计年收入将翻三倍至3500万美元并实现盈利

Nexgel签署最终协议获授权并收购商业化阶段再生生物材料产品组合

NEXGEL, INC.潜在收购案须待双方尽职调查完成

Nexgel公布179.7万美元融资计划关联收购交易拟于2026年第一季度完成尽职调查成关键前提

NEXGEL, INC.获得Diesis Holdings, LLC的Eric Gruntfest追加投资，并任命其为董事会观察员和战略顾问

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"澳洲华人首选美澳港股一站式交易平台 | 老虎证券","description":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","keywords":"老虎证券,老虎证券澳洲,老虎证券股票,老虎证券开户,老虎证券app,tigertrade老虎证券,股票,asx美股,炒股,券商,澳洲股票交易,澳大利亚炒股","social":{"ogDescription":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/NXGLW/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"NXGLW","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NXGLW\",,,,,undefined,":{"symbol":"NXGLW","market":"US","secType":"STK","nameCN":"NexGel Equity Warrant Exp 17th Dec 2026 Warrant","latestPrice":0.0592,"timestamp":1773691200000,"preClose":0.05,"halted":0,"volume":4762,"delay":0,"changeRate":0.184,"floatShares":8067580,"shares":8067580,"eps":-0.3796,"marketStatus":"盘前交易","change":0.0092,"latestTime":"03-17 04:35:41 EDT","open":0.0456,"high":0.0592,"low":0.0401,"amount":203.6047,"amplitude":0.382,"askPrice":0,"askSize":0,"bidPrice":0.039,"bidSize":100,"shortable":0,"etf":0,"ttmEps":-0.3796,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1773754200000},"marketStatusCode":1,"adr":0,"listingDate":1640149200000,"exchange":"NASDAQ","adjPreClose":0.0592,"volumeRatio":0.08171712333347522},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NXGLW\",,,,,undefined,":{"symbol":"NXGLW","floatShares":8067580,"roa":"-19.51%","roe":"-60.47%","lyrEps":0,"volumeRatio":0.08171712333347522,"shares":8067580,"dividePrice":0,"high":0.0592,"amplitude":0.382,"preClose":0.05,"low":0.0401,"week52Low":0.0377,"pbRate":"0.10","psRate":"0.04","week52High":0.4958,"institutionHeld":0,"latestPrice":0.0592,"committee":1,"eps":-0.3796,"divideRate":0,"volume":4762,"delay":0,"ttmEps":-0.3796,"open":0.0456,"prevYearClose":0.2351,"prevWeekClose":0.05,"prevMonthClose":0.1485,"prevQuarterClose":0.2351,"fiveDayClose":0.1699,"twentyDayClose":0.14,"sixtyDayClose":0.197},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NXGLW\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NXGLW\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NXGLW\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NXGLW\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1106679764","title":"Nexgel披露授权与收购商业化阶段再生生物材料产品组合协议的具体条款","url":"https://stock-news.laohu8.com/highlight/detail?id=1106679764","media":"美股速递","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1106679764?lang=zh_cn&edition=fundamental","pubTime":"2026-03-12 21:06","pubTimestamp":1773320791,"startTime":"0","endTime":"0","summary":"Nexgel公司已公布其授权并收购一系列商业化阶段再生生物材料产品组合的协议考量条款。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CELU","NXGLW","NXGL","BK4139","BK4198"],"gpt_icon":0},{"id":"1134454050","title":"Nexgel达成协议 预计年收入将翻三倍至3500万美元并实现盈利","url":"https://stock-news.laohu8.com/highlight/detail?id=1134454050","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134454050?lang=zh_cn&edition=fundamental","pubTime":"2026-03-12 21:06","pubTimestamp":1773320783,"startTime":"0","endTime":"0","summary":"Nexgel公司近日宣布达成一项具有里程碑意义的合作协议。该交易预计将使公司年收入实现三倍增长，达到3500万美元规模，并在交易完成后立即推动公司实现盈利目标。\n这项战略性合作将显著提升Nexgel在凝胶材料领域的市场地位。收入的大幅增长将为企业带来充足的现金流，为后续的研发投入和市场扩张提供有力支撑。分析指出，此次合作不仅能够快速改善公司的财务状况，还将为长期可持续发展奠定坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NXGL","CELU","BK4198","BK4139","NXGLW"],"gpt_icon":0},{"id":"1111760684","title":"Nexgel签署最终协议 获授权并收购商业化阶段再生生物材料产品组合","url":"https://stock-news.laohu8.com/highlight/detail?id=1111760684","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111760684?lang=zh_cn&edition=fundamental","pubTime":"2026-03-10 20:45","pubTimestamp":1773146715,"startTime":"0","endTime":"0","summary":"Nexgel公司已正式签署具有约束力的最终协议，将授权并收购一系列处于商业化阶段的革命性再生生物材料产品组合。该交易标志着公司正式进军高增长潜力的再生医学领域，通过整合成熟技术平台与现有产品线形成协同效应。此次收购的产品组合包含多款经临床验证的生物材料，可广泛应用于创伤修复、组织工程等医疗场景。协议执行后，Nexgel将获得相关产品的全球商业化权利及生产技术，预计将显著增强其在高端医疗器械市场的竞争力。此次战略布局有望为公司开辟新的收入来源，并推动其向综合性生物医学解决方案提供商转型。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NXGLW","BK4139","BK4198","CELU","NXGL"],"gpt_icon":0},{"id":"1157188735","title":"NEXGEL, INC.潜在收购案须待双方尽职调查完成","url":"https://stock-news.laohu8.com/highlight/detail?id=1157188735","media":"美股速递","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157188735?lang=zh_cn&edition=fundamental","pubTime":"2026-02-10 22:07","pubTimestamp":1770732448,"startTime":"0","endTime":"0","summary":"NEXGEL, INC.近期披露的潜在收购交易仍存在不确定性，最终能否达成将取决于收购方与NEXGEL自身尽职调查程序的完整执行。根据公开信息，该交易尚处于初步评估阶段，双方需对财务、法律及运营状况进行全面核查后方可推进。此次潜在收购的推进节奏呈现出明显的阶段性特征：一方面，NEXGEL需要审慎评估收购方案对公司长期战略的契合度；另一方面，投资方也需通过尽职调查验证标的资产的真实价值。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NXGLW","BK4198","NXGL"],"gpt_icon":0},{"id":"1173301360","title":"Nexgel公布179.7万美元融资计划 关联收购交易拟于2026年第一季度完成 尽职调查成关键前提","url":"https://stock-news.laohu8.com/highlight/detail?id=1173301360","media":"美股速递","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173301360?lang=zh_cn&edition=fundamental","pubTime":"2026-02-10 22:01","pubTimestamp":1770732075,"startTime":"0","endTime":"0","summary":"生物材料公司Nexgel近日披露一项总额达179.7万美元的融资安排，该资金将专项用于支持一项战略性收购项目。根据最新规划，此次收购交易预计将于2026年第一季度完成最终交割，但最终时间表将取决于尽职调查程序的顺利完成。此次融资方案与收购计划形成紧密联动，体现出公司通过外部扩张实现业务增长的明确战略意图。作为一家专注于先进水凝胶技术研发的企业，Nexgel此次资本运作彰显了其通过并购加速技术商业化进程的战略布局。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NXGLW","BK4198","NXGL"],"gpt_icon":0},{"id":"1164023238","title":"NEXGEL, INC.获得Diesis Holdings, LLC的Eric Gruntfest追加投资，并任命其为董事会观察员和战略顾问","url":"https://stock-news.laohu8.com/highlight/detail?id=1164023238","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164023238?lang=zh_cn&edition=fundamental","pubTime":"2025-12-16 21:02","pubTimestamp":1765890147,"startTime":"0","endTime":"0","summary":"NEXGEL, INC.获得Diesis Holdings, LLC的Eric Gruntfest追加投资，并任命其为董事会观察员和战略顾问","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NXGLW","BK4198","NXGL"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":6,"code":"91000000","status":"200"}]}}